File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Conference Paper: Immunoexpression of p16 in uterine leiomyomas with infarct type necrosis

TitleImmunoexpression of p16 in uterine leiomyomas with infarct type necrosis
Authors
Issue Date2015
PublisherNature Publishing Group. The Journal's web site is located at http://www.nature.com/modpathol/
Citation
The 104th Annual Meeting of the United States and Canadian Academy of Pathology (USCAP 2015), Boston, MA., 21-27 March 2015. In Modern Pathology, 2015, v. 28 suppl. S2, p. 291A, abstract no. 1162 How to Cite?
AbstractBACKGROUND: The cell cycle marker p16 has been shown to be overexpressed in uterine leiomyosarcomas and theoretically useful for distinguishing between benign and malignant smooth muscle tumors. Its use is limited in routine practice because it has been noted to show variable expression in benign histological variants, specifically, leiomyoma with bizarre nuclei, a tumor that is difficult to distinguish from leiomyosarcoma. The expression of p16 in other benign variants, particularly those with problematic histological features, has seldom been studied. DESIGN: p16 expression pattern in 35 benign uterine leiomyomas with infarct type necrosis were studied. Any staining in the nucleus and/or cytoplasm was considered positive. The extent of positive staining surrounding the infarct was classified as none, <33%, 33-66% and >66%. The extent of staining in areas away from the infarct was classified as none, scattered/isolated, <33%, 33-66% and >66%. Clinical and drug histories and follow-up were also obtained. RESULTS: Age of patients was 23-55 years (median, 43.6), and presentations were menorrhagia, pain, mass, or combinations thereof. 25 were treated with hysterectomy and the remainder with myomectomy. Preoperative drugs (oral contraceptives/GnRH-a/tranexamic acid) were prescribed in 18. One was pregnant. Tumor sizes ranged from 1.5-24 cm (mean, 7.8). All tumors had absent-to-mild atypia except for one case in which the atypia was mild-to-moderate. The mean mitotic count was 1.4/10HPFs (ranged 0-16). All had unequivocal infarct-type necrosis. The extent of p16 positivity in areas surrounding the infarct was 0 in 3 cases (8.6%); <33% in 25 cases (71.4%); 33-66% in 4 cases (11.4%) and >66% in 3 cases (8.6%). The extent of p16 positivity in areas away from the infarct was 0 in 4 cases (11.4%); scattered/isolated in 21 cases (60%); <33% in 8 cases (22.9%); 33-66% in 1 case (2.9%) and >66% in 1 case (2.9%). None of the patients, including those with tumors that showed >66% p16 positivity, developed recurrence after a mean follow-up of 41.4 months (range 1-126). CONCLUSIONS: p16 expression in benign uterine leiomyomas with infarct type necrosis is common, particularly concentrated in tumor cells surrounding an infarct. Its utility in leiomyomas with uncertain type of necrosis may be limited. [Equal contributions from authors 1&2].
DescriptionPoster Session 5 - Gynecologic and Obstetric Pathology: no. 150
This journal suppl. entitled: United States & Canadian Academy of Pathology 104th Annual Meeting Abstracts
Persistent Identifierhttp://hdl.handle.net/10722/211502
ISSN
2015 Impact Factor: 5.485
2015 SCImago Journal Rankings: 2.803

 

DC FieldValueLanguage
dc.contributor.authorIp, P-
dc.contributor.authorLim, D-
dc.contributor.authorCheung, A-
dc.contributor.authorOliva, E-
dc.date.accessioned2015-07-16T01:25:21Z-
dc.date.available2015-07-16T01:25:21Z-
dc.date.issued2015-
dc.identifier.citationThe 104th Annual Meeting of the United States and Canadian Academy of Pathology (USCAP 2015), Boston, MA., 21-27 March 2015. In Modern Pathology, 2015, v. 28 suppl. S2, p. 291A, abstract no. 1162-
dc.identifier.issn0893-3952-
dc.identifier.urihttp://hdl.handle.net/10722/211502-
dc.descriptionPoster Session 5 - Gynecologic and Obstetric Pathology: no. 150-
dc.descriptionThis journal suppl. entitled: United States & Canadian Academy of Pathology 104th Annual Meeting Abstracts-
dc.description.abstractBACKGROUND: The cell cycle marker p16 has been shown to be overexpressed in uterine leiomyosarcomas and theoretically useful for distinguishing between benign and malignant smooth muscle tumors. Its use is limited in routine practice because it has been noted to show variable expression in benign histological variants, specifically, leiomyoma with bizarre nuclei, a tumor that is difficult to distinguish from leiomyosarcoma. The expression of p16 in other benign variants, particularly those with problematic histological features, has seldom been studied. DESIGN: p16 expression pattern in 35 benign uterine leiomyomas with infarct type necrosis were studied. Any staining in the nucleus and/or cytoplasm was considered positive. The extent of positive staining surrounding the infarct was classified as none, <33%, 33-66% and >66%. The extent of staining in areas away from the infarct was classified as none, scattered/isolated, <33%, 33-66% and >66%. Clinical and drug histories and follow-up were also obtained. RESULTS: Age of patients was 23-55 years (median, 43.6), and presentations were menorrhagia, pain, mass, or combinations thereof. 25 were treated with hysterectomy and the remainder with myomectomy. Preoperative drugs (oral contraceptives/GnRH-a/tranexamic acid) were prescribed in 18. One was pregnant. Tumor sizes ranged from 1.5-24 cm (mean, 7.8). All tumors had absent-to-mild atypia except for one case in which the atypia was mild-to-moderate. The mean mitotic count was 1.4/10HPFs (ranged 0-16). All had unequivocal infarct-type necrosis. The extent of p16 positivity in areas surrounding the infarct was 0 in 3 cases (8.6%); <33% in 25 cases (71.4%); 33-66% in 4 cases (11.4%) and >66% in 3 cases (8.6%). The extent of p16 positivity in areas away from the infarct was 0 in 4 cases (11.4%); scattered/isolated in 21 cases (60%); <33% in 8 cases (22.9%); 33-66% in 1 case (2.9%) and >66% in 1 case (2.9%). None of the patients, including those with tumors that showed >66% p16 positivity, developed recurrence after a mean follow-up of 41.4 months (range 1-126). CONCLUSIONS: p16 expression in benign uterine leiomyomas with infarct type necrosis is common, particularly concentrated in tumor cells surrounding an infarct. Its utility in leiomyomas with uncertain type of necrosis may be limited. [Equal contributions from authors 1&2].-
dc.languageeng-
dc.publisherNature Publishing Group. The Journal's web site is located at http://www.nature.com/modpathol/-
dc.relation.ispartofModern Pathology-
dc.titleImmunoexpression of p16 in uterine leiomyomas with infarct type necrosis-
dc.typeConference_Paper-
dc.identifier.emailIp, P: philipip@hku.hk-
dc.identifier.emailCheung, A: anycheun@hkucc.hku.hk-
dc.identifier.authorityIp, P=rp01890-
dc.identifier.authorityCheung, A=rp00542-
dc.identifier.doi10.1038/modpathol.2015.17-
dc.identifier.hkuros244966-
dc.identifier.volume28-
dc.identifier.issuesuppl. S2-
dc.identifier.spage291A, abstract no. 1162-
dc.identifier.epage291A, abstract no. 1162-
dc.publisher.placeUnited Kingdom-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats